ZymoGenetics Punches Bristol-Myers With Suit

Law360, New York (August 15, 2006, 12:00 AM EDT) -- Drug developer ZymoGenetics Inc. has hit Bristol-Myers Squibb Co. with a lawsuit, accusing the pharmaceutical giant of infringing on its patented fusion protein technology.

On Monday, the company revealed that it had filed suit in the U.S. District Court for the District of Delaware, alleging that Bristol-Myers had violated its intellectual property.

"We have a number of patents on fusion protein technology, which we believe are being infringed by Bristol-Myers Squibb," said Bruce L.A. Carter, the president and chief executive officer of ZymoGenetics. "It is important...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.